CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

Abbott Point Of Care Inc. recalls i-STAT G3+ cartridge and 2 more

Read the official FDA notice

Published
6 May 2026
Units affected
3 products
Agency
FDA
Country
United States

The hazard

Approximately 7.6% of cartridges from specific i-STAT EG7+ (list number 03P76-25), i-STAT EG6+ (list number 03P77-25) and i-STAT G3+ (list number 03P78-26) cartridge lots in the U.S. marketplace may report higher than expected PCO2 and lower than expected pH results due to a manufacturing issue. A falsely high pCO2 together with a falsely low pH makes the blood gas appear as if the patient is in severe respiratory acidosis. If the clinician believes the values are real, it may trigger unnecessary or even harmful interventions such as unnecessary ventilator changes, unnecessary medications, potential harm from overcorrection, or delays in identifying true problems.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.

  • Check the model and lot or serial number on the device label.
  • Speak to your doctor or the clinic that supplied the device before stopping use.
Read the official FDA notice

Product details

i-STAT G3+ cartridge; List Number: 03P78-26;

i-STAT EG7+ cartridge; List Number: 03P76-25;

i-STAT EG6+ cartridge; List Number: 03P77-25;

Brand / company
Abbott Point Of Care Inc.
Codes / lots
List Number: 03P78-26; UDI-DI: 00054749005673; Lot number: N25221; | List Number: 03P76-25; UDI-DI: 00054749000043; Lot numbers: N25206, N25207, N25209, N25213, N25218, N25219, N25233; | List Number: 03P77-25; UDI-DI: 00054749000050; Lot number: N25223A;
Distribution
Worldwide distribution - US Nationwide and the countries of Canada, AUSTRIA, BANGLADESH, BELGIUM, FINLAND, FRANCE, GERMANY, IRELAND, ITALY, LUXEMBOURG, MAURITIUS, NETHERLANDS, NORWAY, POLAND, PORTUGAL, SPAIN, SWEDEN, SWITZERLAND, UNITED KINGDOM.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 6 May 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.